Tumor Biology
An overview of targeted alpha therapy
Analysis of the expression of angiotensin II type 1 receptor and VEGF in endometrial adenocarcinoma with different clinicopathological characteristics
CA 19–9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer
Clinical and molecular detection of inherited colorectal cancers in northeast Italy
Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer
C-reactive protein level predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy
CYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis
DM-1, sodium 4-[5-(4-hydroxy-3-methoxyphenyl)-3-oxo-penta-1,4-dienyl]-2-methoxy-phenolate: a curcumin analog with a synergic effect in combination with paclitaxel in breast cancer treatment
Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients
Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for 99mTc-labelling at the C terminus
Expression and clinical significance of Notch signaling genes in colorectal cancer
Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis
Genetic polymorphisms of ALDH2 and ADH2 are not associated with risk of hepatocellular carcinoma among East Asians
ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging
Impact of expression system on the function of the C6.5 diabody PET radiotracer
Introduction to this special issue on tumor targeting
Long-term adaptation of the human lung tumor cell line A549 to increasing concentrations of hydrogen peroxide
Molecules involved in epithelial–mesenchymal transition and epithelial–stromal interaction in phyllodes tumors: implications for histologic grade and prognosis
mTORC1 inhibition and ECM–cell adhesion-independent drug resistance via PI3K–AKT and PI3K–RAS–MAPK feedback loops
Novel aspect of chemophototherapy in treatment of cancer
Nuclisome—targeting the tumor cell nucleus
Overexpression of RIN1 associates with tumor grade and progression in patients of bladder urothelial carcinoma
PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
Pharmacogenetic role of ERCC1 genetic variants in treatment response of platinum-based chemotherapy among advanced non-small cell lung cancer patients
Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors
Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)
Pretargeting: taking an alternate route for localizing radionuclides
Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients
Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol
Targeted therapy in head and neck cancer
The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines
The role of nuclear medicine in modern therapy of cancer
Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker
Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer
Vascular endothelial growth factor A gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India)